Telephone Support for Breast Cancer Treatment Adherence
What You Need to Know Before You Apply
What is the purpose of this trial?
This pilot trial studies a telephone-based intervention to see if it increases adherence to adjuvant hormonal therapy in patients with breast cancer. Increasing communication between doctors and patients with breast cancer may help patients to better follow recommendations on taking adjuvant hormonal treatment medication. A telephone-based intervention may help to increase doctor-patient communication and patients' adherence to their prescribed medication.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, it focuses on helping you stick to your prescribed adjuvant hormonal therapy for breast cancer.
Is telephone support for breast cancer treatment adherence safe?
The research indicates that while adjuvant hormone therapy (a type of treatment for breast cancer) can have side effects, these are generally related to adherence issues rather than safety concerns. No specific safety issues related to telephone support interventions were identified in the studies.12345
How is adjuvant hormonal therapy for breast cancer different from other treatments?
Adjuvant hormonal therapy for breast cancer is unique because it specifically targets hormone receptor-positive tumors, which are common in breast cancer, by blocking or lowering estrogen levels to prevent cancer growth. Unlike chemotherapy, which attacks all rapidly dividing cells, this therapy is more targeted and is taken orally over a long period to reduce recurrence and improve survival rates.46789
What data supports the effectiveness of the treatment Telephone Support for Breast Cancer Treatment Adherence?
Research shows that adherence to adjuvant endocrine therapy (AET) is crucial for reducing breast cancer recurrence and mortality, but many patients struggle to stick with the treatment. Strategies like improving patient-provider communication and providing frequent feedback have been suggested to enhance adherence, which could be supported by telephone-based interventions.4691011
Who Is on the Research Team?
Michelle Naughton, PhD
Principal Investigator
Ohio State University Comprehensive Cancer Center
Are You a Good Fit for This Trial?
This trial is for post-menopausal women with stages I-III breast cancer who've finished primary treatment and are starting adjuvant hormonal therapy (AHT) like tamoxifen or aromatase inhibitors. Participants must own a smartphone, agree to text communication, consent to medical record review, and plan to stay in the study area for at least 3 months.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive daily text messages reminding them to take AHT and weekly interactive surveys delivered by a smartphone app
Follow-up
Participants are monitored for adherence and feedback on the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Adjuvant Hormonal Therapy
- Telephone-Based Intervention
Adjuvant Hormonal Therapy is already approved in European Union, United States, Canada, Japan for the following indications:
- Breast cancer
- Prostate cancer
- Endometrial cancer
- Breast cancer
- Prostate cancer
- Endometrial cancer
- Uterine cancer
- Breast cancer
- Prostate cancer
- Endometrial cancer
- Breast cancer
- Prostate cancer
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University Comprehensive Cancer Center
Lead Sponsor
Alliance for Clinical Trials in Oncology
Collaborator